HEADER TRANSCRIPTION 14-JUN-07 2Z4B TITLE ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN COMPLEXED TO A BENZOPYRAN TITLE 2 LIGAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR BETA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN (RESIDUES 251-505); COMPND 5 SYNONYM: ER-BETA; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS NUCLEAR RECEPTOR LIGAND BINDING DOMAIN, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG REVDAT 5 21-FEB-24 2Z4B 1 REMARK SEQADV REVDAT 4 13-JUL-11 2Z4B 1 VERSN REVDAT 3 24-FEB-09 2Z4B 1 VERSN REVDAT 2 18-SEP-07 2Z4B 1 JRNL REVDAT 1 07-AUG-07 2Z4B 0 JRNL AUTH T.I.RICHARDSON,J.A.DODGE,G.L.DURST,L.A.PFEIFER,J.SHAH, JRNL AUTH 2 Y.WANG,J.D.DURBIN,V.KRISHNAN,B.H.NORMAN JRNL TITL BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR BETA AGONISTS JRNL TITL 2 (SERBAS). PART 3: SYNTHESIS OF CYCLOPENTANONE AND JRNL TITL 3 CYCLOHEXANONE INTERMEDIATES FOR C-RING MODIFICATION. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 4824 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17614275 JRNL DOI 10.1016/J.BMCL.2007.06.052 REMARK 2 REMARK 2 RESOLUTION. 2.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1978978.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 23820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.232 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.600 REMARK 3 FREE R VALUE TEST SET COUNT : 868 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.34 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.49 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3822 REMARK 3 BIN R VALUE (WORKING SET) : 0.3000 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 125 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3488 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.52000 REMARK 3 B22 (A**2) : 1.52000 REMARK 3 B33 (A**2) : -3.04000 REMARK 3 B12 (A**2) : 2.44000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.37 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.730 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.480 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.500 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.370 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.590 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 43.52 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 3 : WATER_REP.PAR REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2Z4B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUL-07. REMARK 100 THE DEPOSITION ID IS D_1000027503. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97943 REMARK 200 MONOCHROMATOR : DIAMOND 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23820 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 33.280 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.200 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.48 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.60 REMARK 200 R MERGE FOR SHELL (I) : 0.59300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, PH 8.0, 2M SODIUM CHLORIDE, REMARK 280 4% PEG 6000, VAPOR DIFFUSION, TEMPERATURE 289.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.61233 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 167.22467 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 125.41850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 209.03083 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.80617 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 HIS A 254 REMARK 465 HIS A 255 REMARK 465 ARG A 256 REMARK 465 GLU A 257 REMARK 465 LEU A 258 REMARK 465 LEU A 259 REMARK 465 LEU A 260 REMARK 465 SER A 286 REMARK 465 ALA A 287 REMARK 465 PRO A 288 REMARK 465 PHE A 289 REMARK 465 THR A 290 REMARK 465 GLU A 291 REMARK 465 THR A 415 REMARK 465 ALA A 416 REMARK 465 THR A 417 REMARK 465 GLN A 418 REMARK 465 ASP A 419 REMARK 465 ALA A 420 REMARK 465 ASP A 421 REMARK 465 CYS A 481 REMARK 465 LYS A 482 REMARK 465 ASN A 483 REMARK 465 VAL A 484 REMARK 465 VAL A 499 REMARK 465 LEU A 500 REMARK 465 ARG A 501 REMARK 465 GLY A 502 REMARK 465 CYS A 503 REMARK 465 LYS A 504 REMARK 465 SER A 505 REMARK 465 MET B 249 REMARK 465 HIS B 250 REMARK 465 HIS B 251 REMARK 465 HIS B 252 REMARK 465 HIS B 253 REMARK 465 HIS B 254 REMARK 465 HIS B 255 REMARK 465 ARG B 256 REMARK 465 GLU B 257 REMARK 465 LEU B 258 REMARK 465 LEU B 259 REMARK 465 SER B 286 REMARK 465 ALA B 287 REMARK 465 PRO B 288 REMARK 465 PHE B 289 REMARK 465 THR B 290 REMARK 465 GLU B 291 REMARK 465 THR B 415 REMARK 465 ALA B 416 REMARK 465 THR B 417 REMARK 465 GLN B 418 REMARK 465 ASP B 419 REMARK 465 ALA B 420 REMARK 465 ASP B 421 REMARK 465 CYS B 481 REMARK 465 LYS B 482 REMARK 465 ASN B 483 REMARK 465 VAL B 484 REMARK 465 ARG B 501 REMARK 465 GLY B 502 REMARK 465 CYS B 503 REMARK 465 LYS B 504 REMARK 465 SER B 505 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 261 CG OD1 OD2 REMARK 470 ARG A 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 480 CG CD CE NZ REMARK 470 ARG B 284 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 424 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 480 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O PRO A 358 O PRO B 358 6545 2.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 386 NE - CZ - NH1 ANGL. DEV. = 5.2 DEGREES REMARK 500 ARG B 386 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 283 64.96 65.06 REMARK 500 GLU A 366 -9.39 -56.91 REMARK 500 PRO A 412 6.93 -64.68 REMARK 500 SER B 283 73.09 55.46 REMARK 500 PRO B 412 2.40 -64.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DC8 A 80 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DC8 B 81 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Q70 RELATED DB: PDB REMARK 900 RELATED ID: 2I0G RELATED DB: PDB REMARK 900 RELATED ID: 2I0J RELATED DB: PDB DBREF 2Z4B A 256 505 UNP Q92731 ESR2_HUMAN 256 505 DBREF 2Z4B B 256 505 UNP Q92731 ESR2_HUMAN 256 505 SEQADV 2Z4B MET A 249 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 250 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 251 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 252 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 253 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 254 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS A 255 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B MET B 249 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 250 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 251 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 252 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 253 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 254 UNP Q92731 EXPRESSION TAG SEQADV 2Z4B HIS B 255 UNP Q92731 EXPRESSION TAG SEQRES 1 A 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 A 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 A 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 A 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 A 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 A 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 A 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 A 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 A 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 A 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 A 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 A 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 A 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 A 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 A 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 A 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 A 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 A 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 A 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 A 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER SEQRES 1 B 257 MET HIS HIS HIS HIS HIS HIS ARG GLU LEU LEU LEU ASP SEQRES 2 B 257 ALA LEU SER PRO GLU GLN LEU VAL LEU THR LEU LEU GLU SEQRES 3 B 257 ALA GLU PRO PRO HIS VAL LEU ILE SER ARG PRO SER ALA SEQRES 4 B 257 PRO PHE THR GLU ALA SER MET MET MET SER LEU THR LYS SEQRES 5 B 257 LEU ALA ASP LYS GLU LEU VAL HIS MET ILE SER TRP ALA SEQRES 6 B 257 LYS LYS ILE PRO GLY PHE VAL GLU LEU SER LEU PHE ASP SEQRES 7 B 257 GLN VAL ARG LEU LEU GLU SER CYS TRP MET GLU VAL LEU SEQRES 8 B 257 MET MET GLY LEU MET TRP ARG SER ILE ASP HIS PRO GLY SEQRES 9 B 257 LYS LEU ILE PHE ALA PRO ASP LEU VAL LEU ASP ARG ASP SEQRES 10 B 257 GLU GLY LYS CYS VAL GLU GLY ILE LEU GLU ILE PHE ASP SEQRES 11 B 257 MET LEU LEU ALA THR THR SER ARG PHE ARG GLU LEU LYS SEQRES 12 B 257 LEU GLN HIS LYS GLU TYR LEU CYS VAL LYS ALA MET ILE SEQRES 13 B 257 LEU LEU ASN SER SER MET TYR PRO LEU VAL THR ALA THR SEQRES 14 B 257 GLN ASP ALA ASP SER SER ARG LYS LEU ALA HIS LEU LEU SEQRES 15 B 257 ASN ALA VAL THR ASP ALA LEU VAL TRP VAL ILE ALA LYS SEQRES 16 B 257 SER GLY ILE SER SER GLN GLN GLN SER MET ARG LEU ALA SEQRES 17 B 257 ASN LEU LEU MET LEU LEU SER HIS VAL ARG HIS ALA SER SEQRES 18 B 257 ASN LYS GLY MET GLU HIS LEU LEU ASN MET LYS CYS LYS SEQRES 19 B 257 ASN VAL VAL PRO VAL TYR ASP LEU LEU LEU GLU MET LEU SEQRES 20 B 257 ASN ALA HIS VAL LEU ARG GLY CYS LYS SER HET DC8 A 80 23 HET DC8 B 81 23 HETNAM DC8 (3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A, HETNAM 2 DC8 4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL FORMUL 3 DC8 2(C18 H16 F2 O3) FORMUL 5 HOH *61(H2 O) HELIX 1 1 SER A 264 GLU A 276 1 13 HELIX 2 2 ALA A 292 LYS A 315 1 24 HELIX 3 3 GLY A 318 LEU A 322 5 5 HELIX 4 4 SER A 323 SER A 347 1 25 HELIX 5 5 ASP A 365 LYS A 368 5 4 HELIX 6 6 GLY A 372 LYS A 391 1 20 HELIX 7 7 GLN A 393 ASN A 407 1 15 HELIX 8 8 MET A 410 VAL A 414 5 5 HELIX 9 9 SER A 422 LYS A 443 1 22 HELIX 10 10 SER A 447 ASN A 478 1 32 HELIX 11 11 PRO A 486 HIS A 498 1 13 HELIX 12 12 LEU B 260 LEU B 263 5 4 HELIX 13 13 SER B 264 GLU B 276 1 13 HELIX 14 14 ALA B 292 LYS B 315 1 24 HELIX 15 15 GLY B 318 LEU B 322 5 5 HELIX 16 16 SER B 323 SER B 347 1 25 HELIX 17 17 ASP B 365 CYS B 369 5 5 HELIX 18 18 GLY B 372 LYS B 391 1 20 HELIX 19 19 GLN B 393 ASN B 407 1 15 HELIX 20 20 MET B 410 VAL B 414 5 5 HELIX 21 21 SER B 422 LYS B 443 1 22 HELIX 22 22 SER B 447 ASN B 478 1 32 HELIX 23 23 PRO B 486 LEU B 500 1 15 SHEET 1 A 2 LYS A 353 ALA A 357 0 SHEET 2 A 2 LEU A 360 ASP A 363 -1 O LEU A 362 N LEU A 354 SHEET 1 B 2 LYS B 353 ALA B 357 0 SHEET 2 B 2 LEU B 360 ASP B 363 -1 O LEU B 362 N LEU B 354 SITE 1 AC1 13 MET A 295 LEU A 298 GLU A 305 LEU A 339 SITE 2 AC1 13 ARG A 346 ILE A 373 ILE A 376 PHE A 377 SITE 3 AC1 13 LEU A 380 GLY A 472 HIS A 475 LEU A 476 SITE 4 AC1 13 MET A 479 SITE 1 AC2 14 MET B 295 LEU B 298 GLU B 305 MET B 336 SITE 2 AC2 14 LEU B 339 ARG B 346 ILE B 373 ILE B 376 SITE 3 AC2 14 PHE B 377 LEU B 380 GLY B 472 HIS B 475 SITE 4 AC2 14 LEU B 476 MET B 479 CRYST1 63.523 63.523 250.837 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015742 0.009089 0.000000 0.00000 SCALE2 0.000000 0.018178 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003987 0.00000